Skip to content
Tenfell
Upcoming
Published 08 Jul 2022

Transcatheter Aortic Valve Replacement for Severe High Surgical Aortic Regurgitation (AR)

NHS Supply Chain · United Kingdom

Key facts

Estimated value
£500,000
Contract starts
15 Sep 2022
Contract ends
17 Sep 2024
Buyer type
Health

Description

NHS Supply Chain seeks to establish a non-exclusive framework agreement for the supply of an Aortic Valve replacement device for the treatment of symptomatic aortic regurgitation and aortic stenosis to NHS Supply Chain customers via the non-direct route of supply. Certain products within this framework agreement could be classified as high cost tariff excluded devices and may be considered under the NHS England High Cost Tariff Excluded Devices (HCTED) programme. Trusts who are commissioned to provide specialised services in England are directed to purchase all their requirements through a national supply system through NHS Supply Chain. It is anticipated that initial expenditure will be in the region of £200,000 to £250,000 in the first year of this framework agreement, however this is approximate only and the values may vary depending on the requirements of those bodies purchasing under the framework agreement. The estimated value over the total framework agreement term is £500,000. This framework agreement is separate to the PIN published on Contract Finders 19/05/2022 which relates to TRANSCATHETER HEART VALVE REPAIR AND REPLACEMENT DEVICES, reference 2022/s 000-013448

Categories (CPV)

Similar open tenders

About NHS Supply Chain

Their tenders, awards, contracts coming up for renewal, decision makers and committee papers.

View buyer profile

Their other open tenders

Published by the buyer on Contracts Finder archive (Open Contracting) (Open Government Licence v3.0). Always read the original notice before responding.